Galderma Provides Update on Arbitration Case Regarding Neuromodulator Research and Development Partnership
Business Wire India Galderma (SIX:GALD), the pure-play dermatology category leader, today announced that an International Chamber of Commerce arbitral tribunal issued an award confirming the termination of a 2014 neuromodulator…